NCT06960135Completed
Trifecta Achievement in Open and Laparoscopic Partial Nephrectomy
Predictors of Trifecta Achievement in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors
Source: ClinicalTrials.gov · Last updated 7 May 2025
Brief summary (registry, in English)
Background: Partial nephrectomy (PN) is a reference standard for the management of the cT1 renal mass, primarily due to better preservation of renal function. The aim of this work was to determine trifecta outcomes of open PN (OPN) and laparoscopic PN (LPN) and identify predictive factors for trifecta achievement to evaluate surgical performance, including negative surgical margins, absence of severe surgical complications, and ischemia time less than 25 minutes. Objectives: this study pointing to determine trifecta outcomes of OPN and LPN and to identify predictive factors for trifecta achievement to evaluate surgical performance, including negative surgical margins, absence of severe surgical complications, and Ischemia time less than 25 Minutes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 22 Apr 2025
- Start date
- 1 Jun 2022
- Primary completion date
- 30 May 2024
- Lead sponsor
- South Valley University
- Diseases
- Kidney cancer, Childhood cancers
- NCT number
- NCT06960135
What you commit to
- Study type: Interventional
- Participants enrolled: 70
- From 1 Jun 2022 to the primary completion date, 30 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- • Patients who are unfit for surgery and who's unfit for laparoscopy.
- Patients who are contraindicated for partial nephrectomy. As severe and irreversible coagulopathy. Patients who are indicated for radical nephrectomy (extensive tumor, metastatic tumor).
Who the study is looking for
- • Patients who are fit for surgery.
- Patients with renal tumor who are indicated for partial nephrectomy
- Absolute:
- Solitary kidney.
- Bilateral renal tumor.
- CDK.
- Relative:
- Abnormal contralateral kidney (nephropathy, nephrolithiasis, trauma).
- Metabolic disease associated with renal failure (DM, hypertension).
- Genetic syndrome with tumor multifocality (VHL syndrome). Elective
- 1\. Clinical T1N0M0 Tumor. 2. Peripheral tumor.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SVU hospital Coordinator of this site? Confirm its status | Qena, Egypt | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.